Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole pharmacokinetic and pharmacodynamic study in infants with presumed GERD
2006-001132-45Phase 3Completed
- Sponsor
- Wyeth
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of pantoprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Wyeth. Primary endpoints: Pharmacokinetics and Pharmacodynamics. Started May 2006; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-001132-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001132-45.